NCT01245231 Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01240525 Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers Status UNKNOWN Phase PHASE2
NCT01235117 Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia Status COMPLETED Phase PHASE2
NCT01232855 Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia Status COMPLETED Phase N/A
NCT01232842 Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01230983 Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT01230788 Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia Status TERMINATED Phase NA
NCT01229956 Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01229124 RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01228331 Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL Status COMPLETED Phase PHASE2/PHASE3
NCT01227135 Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia Status UNKNOWN Phase PHASE2
NCT01225874 Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL Status COMPLETED Phase NA
NCT01222819 SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients Status TERMINATED Phase PHASE4
NCT01222780 To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer Status COMPLETED Phase PHASE1
NCT01222195 Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS) Status TERMINATED Phase PHASE2
NCT01220297 Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT Status TERMINATED Phase PHASE2
NCT01218477 Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) Status COMPLETED Phase PHASE1/PHASE2
NCT01212926 Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain Status COMPLETED Phase NA
NCT01207843 Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute Leukemias Status COMPLETED Phase N/A